Volume 44, Issue 4, Pages (April 2006)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 67, Issue 3, Pages (September 2017)

Volume 61, Issue 2, Pages (August 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Volume 66, Issue 3, Pages (March 2017)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Volume 42, Issue 4, Pages (April 2005)

Inflammasomes in liver diseases

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

m-TOR inhibitors: What role in liver transplantation?

Volume 65, Issue 5, Pages (November 2016)

m-TOR inhibitors: What role in liver transplantation?

Volume 68, Issue 5, Pages (May 2018)

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Immigration and viral hepatitis

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

Reply to: “DCD consensus and futility in liver transplantation”

Volume 69, Issue 2, Pages (August 2018)

The place of downstaging for hepatocellular carcinoma

Volume 58, Issue 3, Pages (March 2013)

Autoimmune hepatitis: A life-long disease

Jordan J. Feld, Graham R. Foster Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Michael Charlton Clinical Gastroenterology and Hepatology

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

Volume 43, Issue 4, Pages (October 2005)

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Roberto de Franchis, Aleksander Krag Journal of Hepatology

Giovanni Addolorato, Antonio Mirijello, Pablo Barrio, Antoni Gual

Volume 57, Issue 5, Pages (November 2012)

Volume 50, Issue 4, Pages (April 2009)

Immigration and viral hepatitis

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

The impact of intestinal microflora on serum bilirubin levels

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Volume 66, Issue 4, Pages (April 2017)

m-TOR inhibitors: What role in liver transplantation?

New trials and results in systemic treatment of HCC

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

Donor-recipient matching: Myths and realities

Chimeric mouse model of hepatitis B virus infection

Comment on the article “Age and liver transplantation”

MELD: the holy grail of organ allocation?

Volume 44, Issue 4, Pages (April 2006)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Fondaparinux (Arixtra∗) hepatotoxicity in a 6 year-old child

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 44, Issue 4, Pages 702-709 (April 2006) Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence Giuseppe Tisone, Giuseppe Orlando, Andrea Cardillo, Giampiero Palmieri, Tommaso Maria Manzia, Leonardo Baiocchi, Raffaella Lionetti, Alessandro Anselmo, Luca Toti, Mario Angelico Journal of Hepatology Volume 44, Issue 4, Pages 702-709 (April 2006) DOI: 10.1016/j.jhep.2005.11.047 Copyright © 2006 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Actuarial occurrence of acute rejection in the 22 patients who completed the cyclosporine A weaning off protocol achieving complete drug withdrawal. Journal of Hepatology 2006 44, 702-709DOI: (10.1016/j.jhep.2005.11.047) Copyright © 2006 European Association for the Study of the Liver Terms and Conditions